Correlation between myocardial infarction (MI) scar by cardiac magnetic resonance and the Lown’s classification of ventricular premature beats (VPBs) is poorly understood. This study aims to investigate the correlation between the MI scar characteristics by delayed-enhancement magnetic resonance imaging (DE-MRI) and the Lown’s classification of VPBs.
METHODS:
Sixty-five patients, in the convalescence stage and consolidation phase of MI, were included in this retrospective study. All patient were divided into VPBs group (n = 39) and non-VPBs group (n = 26 patients) according to the clinical diagnostic criteria of Universal Definition of MI scar. VPBs patients were assigned to Lown’s I-II group and Lown’s III-IV subgroup in accordance with the Lown classification criteria. Cardiac function parameters and MI scar characteristics were detected by cardiac magnetic resonance (CMR) and DE-MRI, respectively.
RESULTS:
Lown’s classification was negatively correlated with left ventricular ejection fraction (LVEF), peak ejection rate (PER) and peak filling rate (PFR) (–0.724, –0.628, –0.559), and positively correlated with MI area, MI integral, MI segments number and left ventricular end systolic volume (LVESV) (0.673, 0.655, 0.586, and 0.514), respectively.
CONCLUSIONS
The study indicated that MI area and MI integral were strongly associated with Lown’s classification.
P.Monney, G.Vincenti, P.G.Masci, T.Rutz, A.G.Pavon, E.Pruvot, J.Schwitter, Myocardial fibrosis detected by cardiac MR: A substrate for ventricular arrhythmias and sudden cardiac death, Rev Med Suisse14 (2018), 1062–1069.
2.
W.Wang, Q.F.Chen, R.X.Yin, J.J.Zhu, Q.B.Li, H.H.Chang, Y.B.Wu, E.Michelson, Clinical features, risk factors, and treatment experience: A review of 74 patients with ST-segment elevation myocardial infarction complicated by ventricular fibrillation, J Emerg Med47 (2014), 729–735.
3.
D.Horvat, J.Vincelj, Impact of reperfusion therapy and infarct localization on frequency of premature ventricular beats in acute myocardial infarction, Med Glas (Zenica)12 (2015), 139–143.
4.
J.A.Barrabes, J.Inserte, L.Agullo, Rodriguez-SinovasA., Alburquerque-BejarJ.J. and Garcia-DoradoD., Effects of the Selective Stretch-Activated Channel Blocker GsMtx4 on Stretch-Induced Changes in Refractoriness in Isolated Rat Hearts and on Ventricular Premature Beats and Arrhythmias after Coronary Occlusion in Swine, PLoS One10 (2015), e0125753.
5.
T.B.Graboys, B.Lown, P.J.Podrid, R.DeSilva, Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs, Am J Cardiol50 (1982), 437–443.
6.
J.Schwitter, C.M.Wacker, N.Wilke, Al-SaadiN., E.Sauer, K.Huettle, SchönbergS.O., A.Luchner, O.Strohm, H.Ahlstrom, MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: Perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: A comparative multicentre, multivendor trial, European Heart Journal (2012), ehs022.
7.
S.R.Dukkipati, J.Sanz, Contrast-enhanced CMR imaging of ventricular tachycardia isthmus sites to guide ablation: An approach in evolution, JACC Cardiovasc Imaging7 (2014), 785–787.
8.
R.Themudo, L.Johansson, Ebeling-BarbierC., L.Lind, H.Ahlstrom, T.Bjerner, The number of unrecognized myocardial infarction scars detected at DE-MRI increases during a 5-year follow-up, Eur Radiol27 (2017), 715–722.
9.
M.J.Ricciardi, E.Wu, C.J.Davidson, K.M.Choi, F.J.Klocke, R.O.Bonow, R.M.Judd, R.J.Kim, Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation, Circulation103 (2001), 2780–2783.
10.
J.S.Alpert, K.Thygesen, E.Antman, J.P.Bassand, Myocardial infarction redefined–a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction, J Am Coll Cardiol36 (2000), 959–969.
11.
M.D.Cerqueira, N.J.Weissman, V.Dilsizian, A.K.Jacobs, S.Kaul, W.K.Laskey, D.J.Pennell, J.A.Rumberger, T.Ryan, M.S.Verani, Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart a statement for healthcare professionals from the cardiac imaging committee of the Council on Clinical Cardiology of the American Heart Association, Circulation105 (2002), 539–5342.
12.
E.B.Schelbert, T.C.Wong, Imaging the area at risk in myocardial infarction with cardiovascular magnetic resonance, J Am Heart Assoc3 (2014).
13.
G.Moravsky, E.Ofek, H.Rakowski, J.Butany, L.Williams, Ralph-EdwardsA., B.J.Wintersperger, A.Crean, Myocardial fibrosis in hypertrophic cardiomyopathy: Accurate reflection of histopathological findings by CMR, JACC: Cardiovascular Imaging6 (2013), 587–596.
14.
N.Sarafoff, T.Ibrahim, The ECG in the setting of myocardial infarction, characterized by cardiac magnetic resonance imaging, J Electrocardiol47 (2014), 129–130.
15.
J.B.Selvanayagam, A.Kardos, J.M.Francis, F.Wiesmann, S.E.Petersen, D.P.Taggart, S.Neubauer, Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization, Circulation110 (2004), 1535–1541.
16.
H.Tandri, M.Saranathan, E.R.Rodriguez, C.Martinez, C.Bomma, K.Nasir, B.Rosen, J.A.Lima, H.Calkins, D.A.Bluemke, Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging, Journal of the American College of Cardiology45 (2005), 98–103.
17.
A.S.Adabag, B.J.Maron, E.Appelbaum, C.J.Harrigan, J.L.Buros, C.M.Gibson, J.R.Lesser, C.A.Hanna, J.E.Udelson, W.J.Manning, Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance, Journal of the American College of Cardiology51 (2008), 1369–1374.
18.
H.B.Hillenbrand, R.J.Kim, M.A.Parker, D.S.Fieno, R.M.Judd, Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging, Circulation102 (2000), 1678–1683.
R.J.Kim, E.Wu, A.Rafael, ChenE-L, M.A.Parker, O.Simonetti, F.J.Klocke, R.O.Bonow and R.M.Judd, The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction, New England Journal of Medicine343 (2000), 1445–1453.
21.
M.Hetland, K.H.Haugaa, S.I.Sarvari, G.Erikssen, E.Kongsgaard, T.Edvardsen, A Novel ECG-Index for Prediction of Ventricular Arrhythmias in Patients after Myocardial Infarction, Annals of Noninvasive Electrocardiology19 (2014), 330–337.
22.
A.E.Buxton, K.L.Lee, G.E.Hafley, L.A.Pires, J.D.Fisher, M.R.Gold, M.E.Josephson, M.H.Lehmann, E.N.Prystowsky, M.Investigators, Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: Lessons from the MUSTT study, Journal of the American College of Cardiology50 (2007), 1150–1157.
